These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1063 related items for PubMed ID: 31577095

  • 1. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer.
    Cicero AFG, Allkanjari O, Busetto GM, Cai T, Larganà G, Magri V, Perletti G, Robustelli Della Cuna FS, Russo GI, Stamatiou K, Trinchieri A, Vitalone A.
    Arch Ital Urol Androl; 2019 Oct 02; 91(3):. PubMed ID: 31577095
    [Abstract] [Full Text] [Related]

  • 2. Phytotherapy for benign prostatic hyperplasia.
    Wilt TJ, Ishani A, Rutks I, MacDonald R.
    Public Health Nutr; 2000 Dec 02; 3(4A):459-72. PubMed ID: 11276294
    [Abstract] [Full Text] [Related]

  • 3. Serenoa repens for benign prostatic hyperplasia.
    Wilt T, Ishani A, Mac Donald R.
    Cochrane Database Syst Rev; 2002 Dec 02; (3):CD001423. PubMed ID: 12137626
    [Abstract] [Full Text] [Related]

  • 4. What do we know about phytotherapy of benign prostatic hyperplasia?
    Allkanjari O, Vitalone A.
    Life Sci; 2015 Apr 01; 126():42-56. PubMed ID: 25703069
    [Abstract] [Full Text] [Related]

  • 5. Serenoa repens for benign prostatic hyperplasia.
    Tacklind J, MacDonald R, Rutks I, Wilt TJ.
    Cochrane Database Syst Rev; 2009 Apr 15; (2):CD001423. PubMed ID: 19370565
    [Abstract] [Full Text] [Related]

  • 6. Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia.
    Russo A, Capogrosso P, La Croce G, Ventimiglia E, Boeri L, Briganti A, Damiano R, Montorsi F, Salonia A.
    Expert Opin Drug Saf; 2016 Dec 15; 15(12):1661-1670. PubMed ID: 27232207
    [Abstract] [Full Text] [Related]

  • 7. Serenoa repens for benign prostatic hyperplasia.
    Tacklind J, Macdonald R, Rutks I, Stanke JU, Wilt TJ.
    Cochrane Database Syst Rev; 2012 Dec 12; 12(12):CD001423. PubMed ID: 23235581
    [Abstract] [Full Text] [Related]

  • 8. Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review.
    MacDonald R, Tacklind JW, Rutks I, Wilt TJ.
    BJU Int; 2012 Jun 12; 109(12):1756-61. PubMed ID: 22551330
    [Abstract] [Full Text] [Related]

  • 9. Serenoa repens for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Current Evidence and Its Clinical Implications in Naturopathic Medicine.
    Ooi SL, Pak SC.
    J Altern Complement Med; 2017 Aug 12; 23(8):599-606. PubMed ID: 28436684
    [Abstract] [Full Text] [Related]

  • 10. Phytotherapy of benign prostatic hyperplasia. A minireview.
    Pagano E, Laudato M, Griffo M, Capasso R.
    Phytother Res; 2014 Jul 12; 28(7):949-55. PubMed ID: 25165780
    [Abstract] [Full Text] [Related]

  • 11. Serenoa Repens, lycopene and selenium: a triple therapeutic approach to manage benign prostatic hyperplasia.
    Minutoli L, Bitto A, Squadrito F, Marini H, Irrera N, Morgia G, Passantino A, Altavilla D.
    Curr Med Chem; 2013 Jul 12; 20(10):1306-12. PubMed ID: 23432584
    [Abstract] [Full Text] [Related]

  • 12. Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project.
    Bertaccini A, Giampaoli M, Cividini R, Gattoni GL, Sanseverino R, Realfonso T, Napodano G, Fandella A, Guidoni E, Prezioso D, Galasso R, Cicalese C, Scattoni V, Armenio A, Conti G, Corinti M, Spasciani R, Liguori G, Lampropoulou N, Martorana G.
    Arch Ital Urol Androl; 2012 Sep 12; 84(3):117-22. PubMed ID: 23210402
    [Abstract] [Full Text] [Related]

  • 13. Pygeum africanum for benign prostatic hyperplasia.
    Wilt T, Ishani A, Mac Donald R, Rutks I, Stark G.
    Cochrane Database Syst Rev; 2002 Sep 12; 1998(1):CD001044. PubMed ID: 11869585
    [Abstract] [Full Text] [Related]

  • 14. A review of animal and human studies for management of benign prostatic hyperplasia with natural products: perspective of new pharmacological agents.
    Azimi H, Khakshur AA, Aghdasi I, Fallah-Tafti M, Abdollahi M.
    Inflamm Allergy Drug Targets; 2012 Jun 12; 11(3):207-21. PubMed ID: 22512478
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and Safety of Hexanic Lipidosterolic Extract of Serenoa repens (Permixon) in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Novara G, Giannarini G, Alcaraz A, Cózar-Olmo JM, Descazeaud A, Montorsi F, Ficarra V.
    Eur Urol Focus; 2016 Dec 12; 2(5):553-561. PubMed ID: 28723522
    [Abstract] [Full Text] [Related]

  • 16. [A comparative analysis of the effectiveness of serenoa repens and serenoa repens in combination with urtica dioiccus for lower urinary symptoms suggestive of benign prostatic hyperplasia associated with chronic inflammation in prostate tissue].
    Ibishev KS, Krainy PA, Mitusov VV, Sizyakin DV, Magomedov GA.
    Urologiia; 2019 Apr 12; (1):40-46. PubMed ID: 31184016
    [Abstract] [Full Text] [Related]

  • 17. Hexanic Extract of Serenoa repens (Permixon®): A Review in Symptomatic Benign Prostatic Hyperplasia.
    Blair HA.
    Drugs Aging; 2022 Mar 12; 39(3):235-243. PubMed ID: 35237936
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of a hexanic extract of Serenoa repens (Permixon® ) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies.
    Vela-Navarrete R, Alcaraz A, Rodríguez-Antolín A, Miñana López B, Fernández-Gómez JM, Angulo JC, Castro Díaz D, Romero-Otero J, Brenes FJ, Carballido J, Molero García JM, Fernández-Pro Ledesma A, Cózar Olmos JM, Manasanch Dalmau J, Subirana Cachinero I, Herdman M, Ficarra V.
    BJU Int; 2018 Dec 12; 122(6):1049-1065. PubMed ID: 29694707
    [Abstract] [Full Text] [Related]

  • 19. [Associating Serenoa repens, Urtica dioica and Pinus pinaster. Safety and efficacy in the treatment of lower urinary tract symptoms. Prospective study on 320 patients].
    Pavone C, Abbadessa D, Tarantino ML, Oxenius I, Laganà A, Lupo A, Rinella M.
    Urologia; 2010 Dec 12; 77(1):43-51. PubMed ID: 20890858
    [Abstract] [Full Text] [Related]

  • 20. Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement.
    Franco JV, Trivisonno L, Sgarbossa NJ, Alvez GA, Fieiras C, Escobar Liquitay CM, Jung JH.
    Cochrane Database Syst Rev; 2023 Jun 22; 6(6):CD001423. PubMed ID: 37345871
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.